Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
From paid studies for healthy volunteers to condition-specific trials, North Carolina offers a wide range of clinical research opportunities. Leading medical centers in Charlotte, Raleigh, and Durham are seeking participants, providing access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 2,450
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Boston MA, Lake Success NY, The Bronx NY, Brooklyn NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
for
Gram-negative Bacterial Infection
Location: Boston MA, Durham NC, Louisville KY, Indianapolis IN,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT06462235
Phase2, Recruiting
Efficacy of 3D-Printed Mouth Splints
for
Microstomia
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 2 - 70+
Code: NCT06801535
Recruiting
Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.
for
Obesity
Location: Chapel Hill NC, Baton Rouge LA, Edmonton
Sponsor: University of Roma La Sapienza
Sex: All
Age: 18+
Code: NCT06545435
Recruiting
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
for
Advanced Cancer, Gastric Cancer, Breast Cancer,
Location: Winston-Salem NC, Birmingham AL, Scottsdale AZ,
Sponsor: Minneamrita Therapeutics LLC
Sex: All
Age: 18+
Code: NCT03129139
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
for
Osteomyelitis Tibia, Tibial Fractures, Open Tibia Fracture
Location: Hershey PA, Winchester VA, Chapel Hill NC,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT05421741
Recruiting
Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Huntersville NC
Sponsor: Nanjing Zenshine Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05118841
Phase1, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase3, Recruiting
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
for
Multiple Myeloma, Monoclonal Gammopathy of Renal Significance
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06083922
Phase2, Recruiting
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
for
Congestive Heart Failure
Location: Roslyn NY, Voorhees NJ, Charlotte NC, Nashville TN,
Sponsor: Southern New Jersey Cardiac Specialists
Sex: All
Age: 18+
Code: NCT00560339
Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
for
Kidney Transplant
Location: Boston MA, New Haven CT, Philadelphia PA, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70
Code: NCT05917522
Phase2, Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
for
Heart Diseases, Coronary Artery Disease,
Location: St. John's, Saint John, Providence RI, Hartford CT,
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18+
Code: NCT04124120
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: St. John's, Trois-Rivieres, Montreal, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06807424
Phase3, Recruiting
Pediatric Dose Optimization for Seizures in Emergency Medical Services
for
Seizures
Location: Washington D.C. DC, Buffalo NY, Pittsburgh PA,
Sponsor: Stanford University
Sex: All
Age: 0 - 13
Code: NCT05121324
Phase3, Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
for
Overactive Bladder, Urinary Urgency Incontinence,
Location: New York NY, Bala-Cynwyd PA, Annapolis MD,
Sponsor: Axonics, Inc.
Sex: Male
Age: 18+
Code: NCT06511141
Recruiting
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT, New Brunswick NJ, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05125016
Phase1, Phase2, Recruiting
Trial for the Use of Pretest Probability to Reduce Unnecessary Testing for Low-Risk Patients With Chest Pain
for
Acute Coronary Syndrome
Location: Charlotte NC
Sponsor: PREtest Consult
Sex: All
Age: 18+
Code: NCT00243516
Phase3, Recruiting
Cancer and Mild Cognitive Impairment Dyadic Intervention
for
Cancer, Cognitive Impairment
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 70+
Code: NCT05144516
Recruiting
Hydrus® Microstent New Enrollment Post-Approval Study